Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents

J Thromb Haemost. 2011 Sep;9(9):1705-12. doi: 10.1111/j.1538-7836.2011.04432.x.

Abstract

The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. In the case of severe bleeding in a patient who uses anticoagulant agents or when a patient on anticoagulants needs to undergo an urgent invasive procedure, it may be useful to reverse anticoagulant treatment. Conventional anticoagulants such as vitamin K antagonists may be neutralized by administration of vitamin K or prothrombin complex concentrates, whereas heparin and heparin derivatives can be counteracted by protamine sulphate. The anti-hemostatic effect of aspirin and other antiplatelet strategies can be corrected by the administration of platelet concentrate and/or desmopressin, if needed. Recently, a new generation of anticoagulants with a greater specificity towards activated coagulation factors as well as new antiplatelet agents have been introduced and these drugs show promising results in clinical studies. A limitation of these new agents may be the lack of an appropriate strategy to reverse the effect if a bleeding event occurs, although experimental studies show hopeful results for some of these agents.

Publication types

  • Review

MeSH terms

  • Anticoagulants / adverse effects*
  • Anticoagulants / antagonists & inhibitors*
  • Antithrombins / adverse effects
  • Antithrombins / antagonists & inhibitors
  • Factor Xa Inhibitors
  • Fondaparinux
  • Hemorrhage / blood
  • Hemorrhage / drug therapy
  • Hemorrhage / etiology*
  • Heparin / adverse effects
  • Heparin Antagonists / administration & dosage
  • Humans
  • International Normalized Ratio
  • Platelet Aggregation Inhibitors / adverse effects*
  • Polysaccharides / adverse effects
  • Polysaccharides / antagonists & inhibitors
  • Risk Factors
  • Vitamin K / administration & dosage
  • Vitamin K / antagonists & inhibitors
  • Warfarin / adverse effects
  • Warfarin / antagonists & inhibitors

Substances

  • Anticoagulants
  • Antithrombins
  • Factor Xa Inhibitors
  • Heparin Antagonists
  • Platelet Aggregation Inhibitors
  • Polysaccharides
  • Vitamin K
  • Warfarin
  • Heparin
  • Fondaparinux